| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | Chemglass Life Sciences Where chemistry meets biology. Chemglass was founded in a small garage in Newfield, New Jersey. The year was 1946. Today, Chemglass Life Sciences has grown into a total of 197,000 square feet, in an expansive, three-building complex located in Vineland, NJ. While scientific glassblowing gave us our start, we have expanded to include four major areas of concentration: scientific and OEM glassware manufacture, bioprocess cleanroom assembly, custom metal and plastic machining and electronics design engineering. We serve many markets. Our customers are typically found in the pharmaceutical, biopharmaceutical, and healthcare industries as well as in all levels of academia. Our … Type: | 0 | 0 | 0 | 94 |
 | Chiesi España [Automatic translation follows] As a B Corp company, we are driven by the #purpose of improving the quality of #people's lives. #SomosChiesi Chiesi is an international research-focused biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases and specialty care. Our mission is to improve people's quality of life and act responsibly for the benefit of the community and the environment. By changing its legal status to Charitable Corporation in Italy, the US and France, Chiesi's commitment to creating shared value for society as a whole is legally binding and central to the company's decision making. … Type: | 15 | 1 | 16 | 257 |
 | Chiesi France [Automatic translation follows] Taking care of patients and the planet today for tomorrow! CHIESI is an Italian family biopharmaceutical group offering innovative therapeutic solutions to patients in 3 therapeutic areas: AIR (products and solutions for respiratory diseases from newborns to adults), RARE (treatments for rare and ultra-rare diseases) , CARE (products and services in kidney and liver transplantation and prevention, in micronutrition) Bringing together nearly 6,500 employees worldwide, CHIESI is present in France across the entire value added chain – R&D, production, distribution and provision to healthcare professionals and patients – with a figure of business reaching nearly €175 million … Type: | 7 | 3 | 4 | 316 |
 | Chiesi Group International pharmaceutical Group certified B Corp. Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, we’re part of a global community of businesses that meet high … Type: | 11 | 3 | 6 | 5,331 |
 | CHPA CHPA is the 141-year-old national trade association representing the leading manufacturers and marketers of OTC meds. Founded in 1881, the Consumer Healthcare Products Association (CHPA) is the national trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system $7.33, contributing a total of $167 billion in savings each year. CHPA is committed to promoting the increasingly vital role of OTC medicines and dietary supplements in America’s healthcare system through science, education, and advocacy. Visit www.chpa.org to learn more. Over-the-counter … Type: | 7 | 0 | 7 | 124 |
 | CID Pharma Packaging [Automatic translation follows] We seek to make life easier for professionals who work in medicinal laboratories. Boxes of medicines with high quality standards, the best delivery dates, and taking care of the environment. Secondary Packaging for Pharmaceutical Industry | 0 | 0 | 0 | 21 |
 |  Cilcare MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, … Type: | 32 | 11 | 27 | 33 |
 | CimQuest | 1 | 0 | 1 | 3 |
 | Cipla Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality … Type: | 7 | 2 | 1 | 41,185 |
 | Civica Rx Serving patients is a privilege that comes with significant responsibilities. Civica Rx was created in late 2018 to secure the supply of important medicines hospitals use every day. As of Q1 2024, we have provided over 155 million units of essential medicines to hospitals, enough to help treat nearly 70 million patients. Recently, we announced we will manufacture and distribute affordable medications for consumers in an outpatient/retail setting, including affordable insulin. Insulin is an exciting project as we are partnering with nearly every corner of the diabetes ecosystem to bring low-cost insulin to people living with diabetes at no more … Type: | 1 | 0 | 0 | 160 |
 | CleveXel Pharma Created in 2013, CleveXel Pharma is a pharmaceutical company with an innovative business model based on maximizing the marketing potential of disruptive molecules in exchange for a stake in the partner's equity or for the gradual purchase of a license. LIFE SCIENCES, PHARMACEUTICAL DEVELOPMENT, CLINICAL RESEARCH, and QUALITY / COMPLIANCE | 0 | 0 | 0 | 15 |
 | CLINACT Contract Research Organisation CLINACT, a MultiHealth Group company, is a Contract Research Organisation (CRO) assisting you in your health products development: pharmaceutical, medical devices, biotechnology, cosmetics, nutrition... With more than 20 years of experience, CLINACT provides its expertise for large range of innovative services: - Clinical operations - Biometrics - Medical and regulatory affairs - Pharmacovigilance, medical device vigilance and other vigilances - E-tools : Clinfile - Outsourcing and recruting : TempoPHARMA - Professional Training : FORMATIS This range of services fully covers industrials or academic organisations' requirements. As a MultiHealth company, CLINACT can also provide specific services withtout any … Type: | 5 | 0 | 5 | 118 |
 | CMIC Group More than 80% of new drug development in Japan is supported by CMIC'S efforts. 実は、日本の新薬誕生の約8割に、私たちシミックの力が活かされています。 CMIC Group was the first company to provide CRO (contract research organization) services in Japan. Relevant laws and rules had not been established when the group was first established. The CRO Study Group (which later became the Japan CRO Association) was formed by Mr. Kazuo Nakamura, the current CEO of CMIC Group, and others to conduct promotion and public relations activities and to negotiate with the authorities for the establishment of CROs in Japan. CMIC Group offers extensive services that encompass an entire value-chain of … Type: | 0 | 0 | 0 | 395 |
 | CNS Summit Collaborating for Novel Solutions! Now in our 14th year, CNS Summit was created by life science leaders to advance clinical development, with a focus on collaboration, innovation, and technology. The CNS Summit is a community of innovators and industry leaders who are not afraid to challenge the status quo. CNS Summit convenes 1000+ decision-makers from organizations involved in clinical development, healthcare innovation, regulatory authorities, investigator sites, and service companies. At CNS Summit, you will experience emerging technologies with practical applications, curated networking and idea sharing, and create collaborative opportunities to propel the future of drug development. You will return to … Type: | 13 | 0 | 13 | 672 |
 | COFARES [Automatic translation follows] Health moves us Cofares is a company established with exclusively pharmaceutical capital that operates with the corporate formula of a cooperative. With a turnover in 2012 of more than 2.5 billion euros, it is the leading medicine distribution company in Spain. Medication distribution Type: | 4 | 1 | 4 | 1,492 |
 | Colorcon® Transforming Innovation into Solutions Colorcon® is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, specialty excipients and functional packaging for the pharmaceutical, nutritional and animal health industries. Our best-in-class products and technologies are complemented by our extensive formulation experience, application data and value-added services to support all phases of solid oral dose design, development and manufacture. Our focus on market issues and technology development has earned Colorcon an international reputation as a pharmaceutical supplier of choice. That reputation is based on superior product quality, unparalleled technical support, extensive regulatory assistance … Type: | 0 | 0 | 0 | 1,203 |
 | Conceptfarma SL [Automatic translation follows] Doing things well is in our DNA Agency specialized in the outsourcing of services that facilitate the management of pharmaceutical laboratories. We work as a team with clients, adapting to their needs and interests and helping them meet their own objectives by assuming the services where they need the most reinforcement. | 0 | 0 | 0 | 12 |
 | Corden Pharma - A Full-Service CDMO The partner you need. CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Lipid Excipients, Drug Products and Packaging. Through a network of cGMP facilities across Europe and the US organized under six technology platforms – Peptides, Lipids & Carbohydrates, Oligonucleotides, Injectables, Highly Potent & Oncology, Small Molecules - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value pharmaceutical products. Visit to learn more > cordenpharma.com Contract Development & Manufacturing Organization (CDMO), Sterile Injectable Drug Products, Aseptic Fill & Finish, Oligonucleotides, Lipid Excipients, LNP Formulation, Peptides, LNP Formulation, Highly … Type: | 2 | 0 | 2 | 1,460 |
 | Corona Remedies Pvt Ltd. Good Health For All & Innovation As Core Spirit CORONA Remedies Private Limited founded in 2004 is an established company, today marks its presence in the top 40 pharmaceutical companies. Teamwork, openness, speed of action & prosperity for each CORONATE are few of the key work values at CORONA. We aim to achieve good health for every individual, society, and nation as a whole. With a mission to make available a range of innovative, value-added, and evidence-based products. Type: | 0 | 0 | 0 | 1,445 |
 | CQDM Facilitateur d'innovation biopharma // Facilitator of biopharma innovation Facilitator of biopharma innovation // Facilitateur d'innovation biopharma. CQDM is a pharma-based consortium active in biopharmaceutical research. Our mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM receives financial support from pharmaceutical companies Amgen, AstraZeneca, GSK, Merck, Pfizer, Roche, Sanofi, Servier, Takeda as well as from Quebec’s Ministère de l'Économie, l'Innovation et de l'Énergie (MEIE). For more information: www.cqdm.org. Le CQDM est un consortium pharmaceutique actif … Type: | 8 | 2 | 8 | 30 |
 | Creapharm, a Myonex company Creapharm, a Myonex company, offers capabilities and flexibility to serve pharmaceutical and biotech companies in both clinical and commercial stages, including companies managing advanced therapies. Beyond decades of experience in Clinical Trial Supply Management, we provide a strong expertise in cold-chain management and recently developed ultra-cold solutions to handle biologicals and ATMP supply chain. For marketed health products, we offer expert commercial packaging services. More globally, Myonex is established throughout Europe (France, Germany and Denmark), UK and in the USA. Clinical GMP Production, Clinical Packaging, Distribution Distribution, International Depot Network, IMP Sourcing and Importation, and Biological sampling kit production | 11 | 2 | 7 | 137 |
 | CREATION.co Better listening for better health We’ve worked in the healthcare sector for more than two decades. In 2012, we developed CREATION Pinpoint – a unique technology platform allowing us to isolate conversations among healthcare professionals, meaning we cut out 95% of the chatter, and focus only on the conversations that matter. CREATION Pinpoint is a proprietary technology platform that uses machine learning to find, listen to and understand what is being said by doctors, nurses, and pharmacists, alongside a team of knowledge engineers who analyze the data to develop customized research insights. The technology maps peer-to-peer relationships between healthcare professionals … Type: | 11 | 0 | 8 | 111 |
 | Creativ-Ceutical Creativ-Ceutical provides strategic pricing, market access and health economics consulting in life sciences. We provide both the strategic advice and the technical services to deliver results that meet your expectations. We have broad experience in the areas of central nervous system (CNS), oncology, vaccines, metabolic/cardiovascular diseases, and rare diseases. These are complex and developing fields, where treatment paradigms are in constant evolution and where clinical and economic issues require rigorous analysis to determine the best therapeutic choices. This experience allows us to address the most complex challenges and to anticipate pricing and market access issues that will arise in other … Type: | 0 | 0 | 0 | 83 |
 | Crossject Expert des médicaments d'urgence auto-administrés Crossject SA (Euronext: ALCJ; www.crossject.com) is an emerging specialty pharma company based in France and the U.S. It is in advanced regulatory development for ZEPIZURE®, an epileptic rescue therapy, for which it was awarded a $60 million contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA). ZEPIZURE® is based on the Company’s award-winning needle-free autoinjector ZENEO®, designed to enable patients and untrained caregivers to easily and instantly deliver emergency medication via intramuscular injection on bare skin or even through clothing. The Company’s other products in development include rescue therapies for allergic shocks, adrenal … Type: | 16 | 7 | 1 | 94 |
 | Crystal Pharmatech A Leading CRO/CDMO for Solid Form & Formulation, Advancing Your PCC to Phase I and Beyond with First-Time-Right Approach Established in 2010, Crystal Pharmatech is a specialized CRO/CDMO, excelling in crystal form and formulation services. Our exceptional track record includes supporting 1,000 clients and collaborating on over 2,000 compounds, showcasing our expertise in solid-state research, crystallization, pre-formulation, formulation development, and manufacturing. With a global presence encompassing three strategically located R&D centers in Suzhou (China), New Jersey (USA), and Toronto (Canada), we are powered by a skilled team of around 250 professionals. As a leader in both conventional and enabling formulation … Type: | 4 | 0 | 4 | 70 |
 | CSE SANOFI AVENTIS FRANCE [Automatic translation follows] The SANOFI AVENTIS FRANCE employee works council. SAF Social and Economic Committee Type: | 0 | 0 | 0 | 7 |
 | CSL Plasma Plasma Donation CSL Plasma is one of the world’s largest collectors of human plasma. We are committed to excellence and innovation in everything we do. Our work ensures that tens of thousands of people with rare and serious diseases are able to live normal, healthy lives. We are committed to our work because people’s lives depend on us. See our community guidelines: https://bit.ly/2IApjpz. Supported by parent company CSL Behring, the global leader in plasma protein biotherapeutics, CSL Plasma has more than 280 plasma collection centers globally. CSL Plasma also has a state-of-the-art testing laboratory that features some of the most … Type: | 0 | 0 | 0 | 5,183 |
 | Curia From curiosity to cure Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 29 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics. To learn more visit us at curiaglobal.com ************************************************** ⚠️NOTICE: Please Be Aware of … Type: | 1 | 0 | 1 | 3,264 |
 | Curlew Research Enabling Life Science using data science, AI and informatics Curlew Research enables better Health & Life Science (H&LS) research through our expertise in informatics, data & strategy development including collaboration, externalisation, data sharing and integration across the complete workflow. We want to develop strong partnerships with organisation to help support their growth and success. We have key experience of working virtually in projects (IMI OpenPhacts, FAIRplus, Transmart Foundation) and in founding and growing organisations such as Pistoia Alliance. informatics, strategy, mhealth, consulting, market research, life science, lab informatics, ML/AI, FAIR data, data management, and drug discovery Type: | 0 | 0 | 0 | 3 |
 | CVS Pharmacy Helping people on their path to better health. CVS Pharmacy is America’s leading retail pharmacy with more than 9,600 locations nationwide. For more than 50 years, CVS/pharmacy has offered customers the products and services they need to stay on their path to better health. In addition to our pharmacies, our stores feature on-trend beauty departments, photo labs and general merchandise. About CVS Health CVS Health is a pharmacy innovation company helping people on their path to better health. Through its approximately 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 75 million … Type: | 32 | 8 | 5 | 48,682 |
 | CYBERNANO Optimize your product development, Quality by Design for all ! CYBERNANO aims to support pharmaceutical, biotech and medtech companies in the Quality-by-Design (QbD) process. The use of QbD is necessary in these high accuracy industries to predict and avoid risks from the early stage of an innovant project. In order to democratize the QbD approach, which requires a lot of effort and expertise, CYBERNANO offers a QbD semi-automated* SaaS platform : « easyQBD ». *(an expert perspective combined to the efficacy of the platform) CYBERNANO a pour vocation d’accompagner les entreprises des secteurs pharmaceutiques, biotechnologiques et des technologies médicales dans … Type: | 8 | 0 | 7 | 6 |
 | Cyclamed [Automatic translation follows] The Cyclamed association, approved by the public authorities, has the mission of collecting and recycling Unused Medicines (UNM) for human use, expired or not, returned by patients to pharmacies. Its objective is to secure the disposal of Unused Medicines, in order to preserve the environment and public health. To these ends, Cyclamed carries out awareness and communication actions among the general public, health professionals and environmental stakeholders. The “Cyclamed Reflex” is a gesture that must be obvious and therefore become a natural gesture. Cyclamed is a non-profit association under the 1901 law bringing together the entire pharmaceutical … Type: | 13 | 4 | 11 | 9 |
 | Cyclopharma Pour répondre aux enjeux de la médecine personnalisée, nous développons des solutions d’imagerie moléculaire innovantes pour l’aide au diagnostic et le suivi thérapeutique en oncologie, neurologie, cardiologie afin d’améliorer la qualité de vie des patients, la sécurité et l’efficacité thérapeutiques tout en réduisant les coûts. To meet the challenges of personalized medecine, we are developing molecular imaging solutions in oncology, neurology, cardiology which improve patients' quality of life, security and therapy efficiency, while reducing costs. radiopharmacy, healthcare, and oncology Type: | 1 | 0 | 1 | 26 |
 | Cytovation Creating transformative medicines for patients with cancer Cytovation is a clinical stage immuno-oncology biotech developing first-in-class immunotherapies. CyPep-1, its lead asset, is a synthetic peptide engineered to selectively target tumor cells. CyPep-1 has a unique dual MoA applicable across solid tumors: (1) direct tumor-specific membrane lysis and in-situ vaccination, combined with (2) immune activation through inhibition of the β-catenin pathway. Building on strong FIH clinical data, Cytovation is advancing CyPep-1 to POC/pivotal clinical development with a focus on b-catenin-driven cancers. Biotech, Oncology, and Immuno-oncology Type: | 0 | 0 | 0 | 13 |
 | Daiichi Sankyo Europe GmbH Passion for Innovation. Compassion for Patients. Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people around the world by leveraging our world-class science and technology. In Europe, we want to become the benchmark for customer centricity in the areas we work in and a competitive player in Oncology. For these reasons we are constantly looking for new talents that are willing to deliver the best solutions to the various healthcare professionals who aim to provide their patients with the best possible therapy - … Type: | 4 | 1 | 1 | 900 |
 | Daiichi Sankyo, Inc. We create life-changing solutions for patients. At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality, life changing solutions for the patients of today and tomorrow with great care and unwavering dedication. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For more information, please visit www.daiichisankyo.us. See our community guidelines here: https://bit.ly/3PYTqYr Daiichi Sankyo, Inc. … Type: | 7 | 1 | 5 | 4,109 |
 | Daiichi Sankyo UK Daiichi Sankyo UK is a pharmaceutical company with corporate origins in Japan. Daiichi Sankyo UK is a pharmaceutical company with corporate origins in Japan. We create and supply innovative products to help the NHS to deliver better patient care in the fields of cardiovascular disease and oncology. Our company was founded in 2006 through the merger of Japanese companies Daiichi and Sankyo in Europe. With a rich legacy of scientific expertise dating back more than 100 years, we are the pioneer behind leading pharmaceuticals that have contributed to the improvement of countless lives across the world. Our mission is to … Type: | 2 | 0 | 2 | 147 |
 | DanCann Pharma A/S - a biopharmaceutical company powered by cannabinoids DanCann Pharma - a biopharmaceutical company powered by cannabinoids | 0 | 0 | 0 | 9 |
 | DCAT (Drug, Chemical & Associated Technologies Association) The Premier Business Development Association for the Global Bio/Pharmaceutical Manufacturing Value Chain Founded in 1890, the Drug, Chemical & Associated Technologies Association, Inc. (DCAT) is a not-for-profit, corporate member-supported, and volunteer-led global business development association for companies engaged in the Bio/Pharmaceutical manufacturing value chain. DCAT has been providing a life-long collegial community for its Member Companies, and their representatives, for over 130 years. DCAT helps build relationships within its unique member company profile that includes the Bio/Pharmaceutical industry’s entire manufacturing value chain. DCAT creates objective, expert-driven education programs and informational services so its Member Companies can easily gain insight into … Type: | 6 | 0 | 6 | 35 |
 | Debiopharm we develop for patients Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If your university … Type: | 6 | 4 | 3 | 494 |
 | Deciphera Pharmaceuticals Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit www.deciphera.com. | 0 | 0 | 0 | 391 |
 | Delta Consultants - Full-service CRO [Automatic translation follows] A partner of the pharmaceutical industry since 1979, DELTA CONSULTANTS has established itself through its dynamism and competence, and perpetuated its activity over the years, gaining the lasting trust of its Clients. Located near Grenoble, the Company benefits from the ambient emulation and the concentration of companies dedicated to new technologies in the capital of the Alps. Methodological advice Study design Data management Statistical analysis Exploratory analysis Report writing Creation of eCRF Monitoring Delta Consultants' evolving procedures are in line with the most recent international recommendations. Each project is subject to the drafting of specific procedures integrating … Type: | 0 | 0 | 0 | 8 |
 | DEMECAN The German Medical Cannabis Expert DEMECAN is the German market leader for medicinal cannabis. As pioneers in the industry, DEMECAN stands as Germany's premier provider of medicinal cannabis. We specialize in the sustainable cultivation and wholesale of medicinal cannabis, offering comprehensive solutions for the German medical cannabis industry. Our focus lies in quality, innovation, and service. With an unwavering goal of providing patients across Germany with top-tier medicinal cannabis, we continuously strive to enhance the quality of life for our customers and broaden access to safe, effective, and sustainable cannabis products. Impressum: https://www.demecan.de/impressum/ Type: | 0 | 0 | 0 | 32 |
 | DIA Empower healthcare innovation with DIA Experience the power of collaborative innovation with DIA (Drug Information Association)!Since 1964, our passionate, volunteer-based global network works together to provide strategic clarity, direction, and policy objectives to offer all stakeholders opportunities to co-create, problem-solve, and illuminate cohesive pathways to the future of global and regional life sciences developments. Join our dynamic, nonprofit organization that serves as a hub for life sciences professionals, academia, advocates, and policymakers worldwide. At DIA, we foster interdisciplinary connections, engaging patients, peers, and visionary leaders in tackling today's challenges and shaping tomorrow's breakthroughs. Unleash your potential with our knowledge resources, … Type: | 11 | 2 | 8 | 461 |
 | Diaceutics PLC Better Testing, Better Treatment At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®. DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. Personalized medicine planning and corporate strategy, Comprehensive commercial planning in personalized medicine, Optimizing return on investment in personalized medicine, Leveraging diagnostics to enhance value in personalized medicine, Understanding … Type: | 4 | 2 | 1 | 200 |
 | Diamyd Medical Developing precision medicine therapies for Type 1 Diabetes Diamyd Medical is a Swedish diabetes company developing precision medicine therapies for Type 1 Diabetes. The therapeutic diabetes vaccine Diamyd , an antigen-specific immunotherapy for the preservation of endogenous insulin production, is being evaluated in the ongoing Phase III trial DIAGNODE-3. The company is establishing a vaccine manufacturing facility in Umeå for the manufacture of recombinant GAD65, the active ingredient in the diabetes vaccine. Diamyd Medical also develops the GABA-based investigational drug Remygen® as a therapy for regeneration of endogenous insulin production and to improve hormonal response to hypoglycaemia. Diamyd Medical is … Type: | 3 | 0 | 2 | 39 |
 | Dicerna Pharmaceuticals, Inc. Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease. Using our proprietary GalXCTM and GalXC-PlusTM RNAi technologies, we discover and develop innovative RNAi-based therapies with the potential to treat both rare and more prevalent diseases. By silencing disease-causing genes, our GalXC platform has the potential to address conditions that are difficult to treat with other modalities. Initially focused on disease-causing genes in the liver, we have continued to innovate and are exploring new applications of our RNAi technology with … Type: | 16 | 0 | 5 | 160 |
 | Dicot AB Dicot is a pharmaceutical company focused on increasing well-being through innovations that enhance sexual health. Dicot is a pharmaceutical company focused on increasing quality of life and well-being through innovations that enhance sexual health. The company develops and manufactures medicines for the treatment of erectile dysfunction and premature ejaculation. The company's lead candidate, LIB-01, is in pre-clinical stage of development. erectile dysfunction, biopharma, premature ejaculation, drug development, pharma, sexual health, lifestyle , drug discovery, lifestyle, drug discovery, drugs from nature, and biopharmaceutical Type: | 0 | 0 | 0 | 7 |
 | DIVERCHIM CDMO API manufacturer of small quantities and GMP excipients supplier Founded in 2000, DIVERCHIM is the leading French company for organic synthesis of original molecules bringing its customers a top level expertise. DIVERCHIM is a Contract Research Organisation (CRO) in organic chemistry. Our teams combine experience in drug discovery and process development, medicinal chemistry, parallel synthesis, biochemical tools and fine chemicals to deliver you with unique chemistry solutions to achieve your requirements. Diverchim specifies in complex multi-steps synthesis, low temperature chemistry, asymmetric, organometallic, cyclopropane, pyrrolidine, oxetane chemistry... Besides Diverchim can scale-up existing processes or develop a new process for existing products. … Type: | 2 | 1 | 1 | 46 |
 | Diversity Alliance for Science The LIFE SCIENCE/ HEALTHCARE Organization to get involved in! Since 2008, Diversity Alliance for Science has been the pre-eminent networking organization for life science companies and diverse-certified suppliers to connect, collaborate and drive the value of diversity. Our networking events are about genuine connections and finding the best way to spark innovation through building business relationships on our diverse perspectives. Our suppliers and corporations build their bottom lines by keeping our shared goals in mind: all the work they produce contributes to making medicines, devices, and ideas that save lives. The best way to get to know our organization is … Type: | 7 | 0 | 7 | 10 |
 |  Doklog [Automatic translation follows] Create your health communication platform Your health information network. Platform intended for all health stakeholders: professionals, patients, establishments, associations, authorities, manufacturers, etc.). health, social media, hcsmeufr, and startup Type: | 1 | 0 | 0 | 0 |
 | Domain Therapeutics #biopharma #biotech #drugdiscovery #GPCR #Immunooncology #immunosuppression Domain Therapeutics, a clinical-stage global biopharmaceutical company, focused on developing innovative immunotherapies targeting G Protein-Coupled Receptors (GPCRs), one of the most important drug target classes, to unlock new possibilities in cancer. As a leader in GPCRs in immuno-oncology, Domain sees cancer differently, using a precise biomarker strategy to address the specific needs of patients based on unique signatures of individual cancers. Two decades of solid experience in GPCR drug discovery, validated by multiple pharma partnerships, associated to a target identification and drug discovery platform enable the Company to enhance the understanding of cancer and … Type: | 13 | 5 | 9 | 90 |
 | DÔMES PHARMA Cultivate our positive impact Dômes Pharma is an independent, family-owned company that has been active in the pharmaceutical industry since 1947. It employs 400 people in France, England, Germany, Spain and the USA and has a consolidated turnover of 90 million euros. For over 70 years, the Group has been developing, manufacturing and marketing solutions for the health and well-being of pets. The Dômes Pharma Group has 3 complementary areas of expertise that integrate the entire value chain of medicine and cover all distribution channels. Animal Health Type: | 14 | 6 | 10 | 119 |
 | Dômes Pharma France [Automatic translation follows] TVM becomes Dômes Pharma Owned by the independent family group since 1982, the products of Laboratoire TVM are now marketed under the name Dômes Pharma, in France and internationally. Dômes Pharma is a wide range of medicines and animal health products that meet the needs of veterinarians’ daily practice. Leader in veterinary ophthalmology, poisoning management and neurology, the Dômes Pharma range is also very well established in specialized niches such as gastroenterology and behavior. Fully committed to improving access to veterinary medicine, we bring relevant improvements and innovation to veterinarians and pet owners in our areas of … | 2 | 1 | 0 | 88 |
 | Dompé We Embrace the Challenge in Science Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up. We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and … Type: | 12 | 1 | 12 | 843 |
 | Dosepharma [Automatic translation follows] Dosepharma, the blistering service provider for pharmacists. Resulting from the association between pharmacy and new technologies, dosepharma allows all pharmacists to benefit from a personalized, safe and effective blistering service. Dosepharma competes with boxes of medicines by delivering treatment individually to partner pharmacies. Technology, Automation, Medicine, Digital, Pharmacy, IT, challenger mindset, and unit sales Type: | 0 | 0 | 0 | 9 |
 | Double Bond Pharmaceutical International AB Double Bond Pharmaceutical is a fast growing pharmaceutical company that develops and commercializes innovative first-in-class approaches for treatment of cancers, infections, autoimmune diseases and other life-threatening disorders. The main aim of the company is to provide patients and the market with more efficient and safe products especially in areas where these needs are unmet. The human population is growing and also the life-span is increasing. Many children born today can be expected to live until they are about 100 years old. By these reasons it can be expected that the need for efficient therapies for treatment of different diseases will … Type: | 0 | 0 | 0 | 14 |
 | Drugabilis CRO specialized in pharmaceutical drugability for research Expertise in Human and Animal health solid form characterization and formulation development. We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. We are member of the association AFSSI, 1st French research center in Life Sciences, as a founding member and member of the board of Directors. Since March 2019 Joel Vacus, Drugabilis CEO & CSO, is the President of AFSSI. https://www.afssi.fr/ Feel free to contact us in order to exchange about your preclinical drug development! contact@drugabilis.com Lead optimization, Formulation, and Physical form optimization Type: | 0 | 0 | 0 | 8 |
 | DrugDev DrugDev is an IQVIA company. DrugDev, an IQVIA company, is an innovative technology company which provides cloud-based solutions to help sponsors, CROs and investigators do more clinical trials together. Built around the largest global network of active opted-in investigators, DrugDev’s unified solutions suite optimizes site selection and startup, investigator payments and clinical operations. DrugDev also serves as the trusted third-party host of the revolutionary Investigator Databank collaboration and powers the TransCelerate Investigator Registry. Site Identification, Protocol Feasibility, Building Investigator Communities, Study Startup, Investigator Payments, Contracts and Essential Site Documents, Investigator Budget Development, and Software Type: | 0 | 0 | 0 | 79 |
 | DrugPatentWatch Pharmaceutical Drug Patent Intelligence Find Your Next Blockbuster - Your single platform for accurate, objective, and timely intelligence Global biopharmaceutical drug patent and generic entry business intelligence. DrugPatentWatch Supports Critical Business Decisions: >Payers: Formulary and pharmacy & therapeutics (P&T) Anticipate future budget requirements and proactively identify generic sources > Branded pharmaceutical manufacturers Assess past successes of patent challengers and elucidate research paths of competitors > Generic manufacturers Inform portfolio management decisions on future drug development > Buyers, wholesalers, and distributors Predict branded drug patent expiration, identify generic suppliers, and prevent overstock of branded drugs > API manufacturers Obtain formulation and manufacturing information; identify final … Type: | 0 | 0 | 0 | 4 |
 | EA Pharma [Automatic translation follows] Your natural health partner: Innovation, Naturalness, Effectiveness and Performance EA Pharma Pharmaceutical Laboratories aim to improve, in a natural way, the quality of life of people concerned about their health, their well-being and their body. Drawing on their research and expertise in the field of micro-nutrition, EA Pharma Laboratories are experts in Nutritherapy Complement therapy and Oligotherapy. Every year, they develop, manufacture and distribute medicines and food supplements with the unifying values of innovation, excellence, quality, transparency and service to the consumer and patient. Their know-how, both in the medical and nutritional fields, leads them to satisfy … Type: | 3 | 1 | 1 | 242 |
 | Early Drug Development Group (E2DG) Boost your program in Oncology We offer professional support all along the drug development life cycle, from lead optimization to Phase I clinical trials in oncology. We optimize and accelerate your R&D programs, based on our drug positioning-oriented philosophy. Early Drug Development Group is focused on building partnerships and strategic alliances with academic research institutions, universities, governmental agencies, small size biotechnology partners and investment funds. COLLABORATION WITH US IMPROVES YOUR RESOURCES INVESTMENT AND STRENGTHENS YOUR EARLY DRUG DEVELOPMENT PROGRAM IN ONCOLOGY. YOUR KEY BENEFITS • Assistance on preclinical, pharmacological and CMC approaches, clinical studies design, regulatory strategies and trials implementation … Type: | 0 | 0 | 0 | 1 |
 | EFPIA - European Federation of Pharmaceutical Industries and Associations Illness never sleeps, so neither can we #WeWontRest The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 41 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world. Twitter : @EFPIA Website : www.efpia.eu Pharmaceutical Industry Type: | 13 | 3 | 11 | 135 |
 | Egualia – Industrie Farmaci Accessibili A better future. For everyone. Egualia (formerly Assogenerici) is the Italian Federation of Industries for Accessible Medicines which today represents more than fifty companies, over 95% of the companies producing generic, biosimilar and value-added medicines. Founded in 1993, it is a member of the European association of the sector, Medicines for Europe, and welcomes multinational and Italian companies present throughout the territory, which produce both for the domestic and foreign markets, as well as companies engaged in the production of drugs on behalf of third parties for the entire pharmaceutical industry. Generics and biosimilars cover 80% of therapeutic areas and … Type: | 7 | 0 | 7 | 18 |
 | Eisai US Breaking through in the therapeutic areas of oncology and neurology. View our community guidelines: https://bit.ly/3dkY At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related … Type: | 17 | 2 | 11 | 2,988 |
 | Eli Lilly and Company For more than a century, we have stayed true to a core set of values – excellence, integrity, and respect for people – that guide us in all we do: discovering medicines that meet real needs, improving the understanding and management of disease, and giving back to communities through philanthropy and volunteerism. General Information and Guidelines: Eli Lilly and Company strives to create informative and engaging online communities that share information in meaningful ways. We welcome and encourage your participation and engagement in thoughtful and respectful discourse. When you engage with Lilly on LinkedIn (and any other of Lilly’s social … Type: | 60 | 16 | 33 | 42,831 |
 | ELRIG UK Bringing the life science and drug discovery communities together to learn, share, connect, innovate and collaborate. The European Laboratory Research and Innovation Group UK (ELRIG) is a not for profit company whose purpose is to bring the life science and drug discovery communities together to learn, share, connect, innovate and collaborate. We achieve this through the provision of world class conferences, networking events, webinars and digital content. Our values are to always ensure the highest quality of content and that content will be made readily accessible to all, and that we will always be an inclusive organisation, serving a diverse … Type: | 4 | 2 | 2 | 24 |
 | EMVO | European Medicines Verification Organisation Securing the legal supply chain from falsified medicines for patient safety in Europe. The European Medicines Verification Organisation “The European Medicines Verification Organisation (EMVO) is the guarantee of patient security in Europe.” The European Medicines Verification Organisation (EMVO) has taken responsibility for advancing the formation of the European Medicines Verification System (EMVS). The EMVS is in accordance with the EU’s Falsified Medicines Directive (FMD) and the Delegated Regulation (DR). It ensures the implementation of a functioning, secure, interoperable and cost effective system across Europe. The infiltration of falsified medicines in the European supply chain is a major and continuous threat … Type: | 3 | 0 | 3 | 30 |
 |  Enterprise Therapeutics Dedicated to the development of novel therapies to improve the lives of patients with respiratory disease Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life. The leadership team has significant expertise in drug discovery, drug development, respiratory biology and ion channel pharmacology. … Type: | 1 | 1 | 1 | 13 |
 | Entourage Health Award-winning cannabis brands & products. Crafted with pride, by people who care. Entourage Health Corp. (previously WeedMD Inc.) is the publicly traded parent company of Entourage Brands Corp. (formerly WeedMD RX Inc.) and CannTx Life Sciences Inc., licence holders and producers of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario as well as a fully-licensed 26,000 sq. ft. Aylmer, Ontario-based extraction, processing and distribution facility. With the addition of Starseed Medicinal, a medical-centric brand, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s … Type: | 1 | 0 | 1 | 127 |
 | ESTEVE Advancing health together At ESTEVE we have a clear purpose: to improve people's lives. We are an international specialty pharmaceutical company with pharma affiliates in Spain, Germany, France, UK, Portugal and Italy. We also have industria sites dedicated to the development and manufacture of active pharmaceutical ingredients in Spain, Mexico and China. Together we work to meet the unmet medical needs of our patients through innovative solutions that are environmentally sustainable, while remaining true to our values in everything we do: people matter, transparency and accountability. Because we care not only about what we do, but also about how we … Type: | 11 | 1 | 7 | 1,744 |
 | Ethon [Automatic translation follows] Searching High Quality Medicines In our desire to fulfill the Company's mission, we have developed alliances with different suppliers worldwide, to import products with high quality standards into our country and thus be able to satisfy the needs of our society. In our country, we are holders of Health Registries for products imported from Europe and Asia. | 0 | 0 | 0 | 55 |
 | Ethypharm Beyond our medicines, lives Ethypharm is a European pharmaceutical company focused on two areas: the Central Nervous System and Hospital Injectables. Ethypharm markets its drugs directly in Europe and China, and with partners in North America and the Middle East where its drugs are in high demand. The Group employs 1,750 people, mainly in Europe and China. Ethypharm works closely with authorities and healthcare professionals to ensure the appropriate use of and access to its medicines, by as many people as possible. For more information on Ethypharm, visit www.ethypharm.com Addiction, Pain, Critical Care, CNS, Hospital Injectable , severe pain, Hospital … Type: | 2 | 1 | 1 | 972 |
 | ETISENSE Jacketed physiological monitoring for life sciences Etisense, is a Lyon (FR) based MedTech company specialized in non-invasive physiological monitoring. Etisense develops unique instrumentation solutions for pre-clinical research and development. DECRO, (www.etisense.com),our 1st product is now available to help scientists to perform pre-clinical research differently. recherche, R&D pharmaceutique, Instruments connectés, and Plateforme d'acquisition de signaux physiologiques Type: | 3 | 1 | 2 | 13 |
 | EURAXI Conception et réalisation de vos projets d'Etudes Cliniques, Registres, Programmes d'Accès précoces, Home Nursing 🚀✨ Euraxi (CRO) is a project management specialist in the health sector, assisting clients with their projects since 1986. Our organisation and service offer have been perfectly tailored to meet the precise needs of our clients. We can take on all or part of your operations thanks to our multidisciplinary team. This team is organised into specialised units and is guided by the risk management and quality procedures inherent to the requirements of your projects. - Clinical Operations - Data Management, eTools & Statistics - Medical … Type: | 1 | 1 | 1 | 115 |
 | Eurofins BioPharma Product Testing Italy Laboratory Testing Excellence Eurofins Biolab S.r.l. is a GMP & GLP Laboratory part of the BioPharma Product Testing Division of Eurofins Scientific. Pharmaceuticals, Medical Devices, Biocides and Cosmetics are our main areas of interest GMP, GLP, ISO 17025, ISO 9001, ISO 13485, ISO 22716, FDA INSPECTED, BioPharmaceutical Testing, Medical Device Testing, Biocide Testing, Cosmetic Testing, Professional Scientific Services, Regulatory and Consultancy, Microbiological and Chemical Testing, Training, and Laboratory Testing Type: | 1 | 1 | 0 | 434 |
 | European Pharmaceutical Review The leading FREE journal for all aspects of drug analysis, formulation, delivery, manufacturing and regulation. European Pharmaceutical Review is the leading FREE resource for up-to-the-minute information on all aspects of drug analysis, formulation, delivery, manufacturing and regulation. Our journal has been keeping the industry updated for more than 25 years and remains faithful to the key facets that serve its existing stakeholders. Our issues deliver a range of high-quality, in-depth, technical contributions from the world’s leading pharmaceutical scientists and business experts, while our digital channel offerings include the latest news, webinars and scientific learning materials. Subscribe for free today, it … Type: | 4 | 0 | 4 | 5 |
 | Europhartech [Automatic translation follows] DOMES PHARMA MANUFACTURING Production site of the Dômes Pharma Group EUROPHARTECH is also CMO (Contract Manufacturing Organization) for the Human and Veterinary Pharmaceutical Industry. Specializing in clinical batches, the production of dry forms and non-sterile liquid forms for human and veterinary use as well as in food supplements, complementary foods and medical devices. EUROPHARTECH also has solid expertise in the originator, hospital ATU/AMM and unit EHPAD BUD, PDA, generic and nutraceutical markets. EUROPHARTECH is a subsidiary of the DÔMES PHARMA Pharmaceutical Group, historically specialized in Animal Health and present in Human Health since 1992. Laboratory approved by … Type: | 2 | 1 | 0 | 73 |
 | eVeDrug [Automatic translation follows] eVeDrug calls on different stakeholders all linked to the field of Pharmacovigilance: professionals from the pharmaceutical industry and scientists who have pooled their know-how, and with their experience acquired both from industrial environments (laboratories and manufacturers ) as well as Institutional environments (health authorities in different countries). eVeDrug wishes above all to restore trust between patients and their health system by placing the main interested party (the patient themselves) at the center of the health system responsible for protecting them. Thus, eVeDrug distributes the free My eReport application which allows any person (patient, relative, health professional, etc.) … Type: | 12 | 2 | 5 | 7 |
 | EVER Pharma (France) [Automatic translation follows] Creator of solutions dedicated to Health EVER Pharma France, a pharmaceutical laboratory, is the French subsidiary of EVER Pharma. EVER Pharma is an independent Austrian laboratory whose activity is fully integrated. Type: | 0 | 0 | 0 | 21 |
 | EVERSANA EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com. Regulatory, Management & Specialty Consulting, Research & Insights, Global Pricing Strategies, Patient, Payer & Provider Marketing Services, Field Medical, Market Access & Sales , Global … Type: | 4 | 1 | 0 | 4,112 |
 | Evotec #researchneverstops Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients. Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing. We aspire to contribute data-driven disease understanding and … Type: | 5 | 2 | 3 | 4,958 |
 | Excellis Health Solutions, an NNIT Group Company We make a mark. Excellis Health Solutions is an NNIT Group Company. Life sciences and public sector professionals can make a direct difference in the lives of the many – and with the digital revolution, the opportunities to make a mark are greater than ever. At NNIT, we bring digital transformation to life. You get a team of leading industry subject-matter experts and technology consultants. We develop, implement, and continuously improve sustainable solutions that help to enhance the quality of life around the globe. We overcome complexities through determined customer centricity and proximity. Our team is built around a pioneering … Type: | 0 | 0 | 0 | 79 |
 | Excelya Expertly delivering clinical trials operations, with care. Excelya is an independent partner that serves Biotech, Pharma, and Medical Device organizations with a comprehensive range of Full-service CRO, FSP, and Resourcing solutions guided by compassion, care, and excellence. Founded in 2014 and headquartered in Paris, France, and operating in 28 countries across Europe, USA and India, Excelya has a global team of 900+ experts who understand the critical needs of clients to provide bespoke and robust trial solutions across a broad spectrum of therapeutic areas, with speciality focus on Oncology & Hematology, Rare Disease & Pediatrics, Infectious Disease, Inflammation & Immunotherapy, … Type: | 8 | 2 | 3 | 702 |
 | Exeliom Biosciences Crossing the next frontier, to give you a fair chance to fight Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms. Inflammatory Bowel Diseases, Live Biotherapeutics, Microbiome, Immunotherapies, Immuno-oncology, and Immuno-inflammation Type: | 10 | 4 | 8 | 8 |
 | Exeltis Rethinking healthcare Exeltis is an organization committed to innovation, excellence and healthcare. Our aim is to become a point of reference in the pharmaceutical sector. A step forward in improving health Exeltis is the result of the natural evolution and sustained growth of Insud Pharma, an integrated health sciences group. It combines the Group’s know-how and experience with the innovative spirit of Exeltis, becoming a global organization with the capacity to discover, develop, produce and market medicinal products and medical devices that can help to improve the quality of life of millions of people worldwide. Human wellbeing and health: our … Type: | 0 | 0 | 0 | 2,295 |
 | eXYSTAT [Automatic translation follows] Quality Honesty Transparency Conviviality Simplicity eXYSTAT is a company of 2 partners created in October 2013 to offer players in the world of health expertise in the field of biometrics for clinical studies. Our ambition is to offer expertise in the field of biometrics and clinical studies that we believe differentiates itself from the existing offering in France at the moment. Our technical expertise, the result of our complementary experiences, covers the areas of clinical trials and epidemiological studies. Within subsidiaries, laboratory parent companies, biotechnology companies and service companies (CROs), our careers have also led us to … Type: | 1 | 0 | 1 | 19 |
 | Fabentech Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields … Tags: FrenchTech2030 Type: | 13 | 4 | 9 | 45 |
 | FAES FARMA Cuidamos de la salud hoy para construir una sociedad más sana mañana Founded in 1933, Faes Farma is a Spanish pharmaceutical company with a wide international presence. The company conducts research, produces and markets pharmaceutical products and raw materials, exporting to numerous countries. With 1,766 employees and headquarters, manufacturing and R&D center in Leioa (Bizkaia), Faes Farma has offices in Madrid and Barcelona, and subsidiaries in Portugal (Laboratorios Vitoria), Italy (with a 51% stake), Mexico, Guatemala, Colombia, Chile, Peru, Ecuador and Nigeria. Faes Farma also has a division dedicated to Animal Nutrition and Health (FARM Faes), which includes companies such … Type: | 3 | 2 | 0 | 1,171 |
 | Farmacias Cruz Verde Chile [Automatic translation follows] The Low Price Pharmacy We are the leading pharmacy chain in Chile, with more than 30 years in the market. Our commitment is to provide access to quality medications and hygiene, personal care, beauty and well-being products at affordable prices, which we reinforce every day through the benefits of the Cruz Verde Club. We have more than 700 stores and 6,300 workers in Chile, reaching isolated areas such as Easter Island and Cerro Sombrero. We even have mobile pharmacies to provide access and coverage of medicines in remote areas of the north and south of Chile. Since … Type: | 1 | 0 | 1 | 3,219 |
 | FARMAFORUM [Automatic translation follows] Forum of the Pharmaceutical, Biopharmaceutical, Cosmetics and Laboratory Technology Industry Farmaforum 2023, Forum of the Pharmaceutical, Biopharmaceutical and Laboratory Technologies Industry, celebrates its ninth edition in Madrid. Once again, the IFEMA facilities have been chosen, specifically pavilion 14 of the Madrid Fair. In its nine years of existence, Farmaforum has managed to consolidate itself as the most important event of the Pharmaceutical Industry in Spain, extending its themes and sharing synergies with the Biotechnology Industry and the Cosmetics Industry, through the special areas Health&Research Forum, Cosméticaforum, Biotechforum , Nutraforum and Cannabisforum. Farmaforum is made up of an … Type: | 2 | 0 | 2 | 11 |
 | FARMAINDUSTRIA Innovation for people Created in 1963, Farmaindustria is the National Association of the Pharmaceutical Industry established in Spain. It brings together most of the innovative pharmaceutical laboratories established in Spain, which accounts for almost all sales of prescription drugs under patent in the country. farmacia, investigación y desarrollo, industria, innovación, salud, sanidad, health, pharma, healthcare, laboratorios, medicamentos, fármacos, pharmaceuticals, medicine, I+D, vacunas, vaccines, and industria farmacéutica Type: | 1 | 0 | 1 | 155 |
 | FARMESPAÑA INDUSTRIAL [Automatic translation follows] Technical magazine of suppliers of the Pharmaceutical Industry and laboratory technology Technical magazine for suppliers of the pharmaceutical industry and laboratory technology. Magazine disseminated by AEPIMIFA, Spanish Association of engineering and maintenance professionals in the pharmaceutical and related industries Type: | 3 | 0 | 3 | 4 |
 | Farmindustria | 4 | 2 | 0 | 214 |
 | Fédération Française des Industries de Santé - FEFIS [Automatic translation follows] The ambition to put its action at the service of public health policy, a source of social and economic progress. Created in 1975, the French Federation of Health Industries – Féfis – brings together eleven professional organizations representing companies which create, manufacture or distribute health products such as human and veterinary medicines, medical devices, optical products, dental products, in vitro diagnostics. A crossroads for exchanges and common actions, Féfis strives to be the spokesperson for a strategic sector of the future for the growth and competitiveness of our country. His commitments within numerous structures – ARIIS, MEDEF, … Type: | 26 | 6 | 21 | 6 |
 | Ferrer We use business to fight for social justice 💙💚 We use business to fight for social justice 💙💚 Chemical, orphan drugs, partnering, hospital products, personal medician, prescripción, and materias primas Type: | 3 | 3 | 0 | 2,018 |
 | Ferring Pharmaceuticals 70 years of building families and helping people live better lives. Guidelines: re.ferring.com/social-guidelines Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceutical group committed to building families and helping people live better lives. We are leaders in reproductive medicine and maternal health, and in areas of gastroenterology and urology. We are at the forefront of innovation in microbiome-based therapeutics and uro-oncology intravesical gene therapy. Ferring was founded in 1950 and employs more than 7,000 people worldwide. The company is headquartered in Saint-Prex, Switzerland, and has operating subsidiaries in more than 50 countries which markets its medicines in over 100 countries. … Type: | 3 | 2 | 1 | 5,810 |
 | Fidia Farmaceutici SpA Italian multinational company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio mainly based on hyaluronic acid (HA) in joint care, skin care, eye care, aesthetic care and regenerative care. Nearly 60 years of R&D have placed Fidia at the forefront in the production of natural and functionalized HA, with different ranges of molecular weight (+1,100 patents). Manufacturing operations – located in Italy - are inspected and approved by major international health authorities, including the US and Korean FDA, the Brazilian ANVISA and G-MED Notified Body, and comply with the strictest international regulations and safety standards. Fidia … Type: | 0 | 0 | 0 | 1,261 |
 | FinVector Oy Discover a unique cGMP, in a unique setting, in a unique country. Welcome to FinVector, Kuopio, Finland. Welcome to FinVector, a leading cGMP manufacturer of viral-based products with a strong commitment to restoring hope, purpose and a true sense of belonging for those living with chronic health conditions. FinVector is owned by Ferring Ventures S/A. Learn more: www.finvector.com Instagram: @finvectorians - https://www.instagram.com/finvectorians/ LinkedIn: FinVector Oy - https://www.linkedin.com/company/finvector/ GMP, Manufacturing, Biopharmaceuticals, Gene therapy, and Virus production Type: | 1 | 0 | 1 | 308 |
 | Fiocruz [Automatic translation follows] Promote health and social development, generate and disseminate scientific and technological knowledge, be an agent of citizenship. These are the concepts that guide the actions of the Oswaldo Cruz Foundation (Fiocruz), linked to the Ministry of Health, the most prominent health science and technology institution in Latin America. International Health Research Center Type: | 0 | 0 | 0 | 3,600 |
SMB